Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
23/03/2026
Brent crude oil futures touched a high of $114.35 per barrel, while WTI crude oil futures reached a high of $101.50 per barrel.
Latest
1 m ago
Asian markets saw a slight decrease in oil prices in the morning session. Traders are keeping an eye on the deadline set by Trump for the reopening of the Strait of Hormuz.
2 m ago
Japanese 10-year government bond yields rose 5 basis points to 2.310%.
2 m ago
Korean Electric Company to freeze electricity price for the second quarter.
4 m ago
Hansen Pharmaceuticals announced that its independently developed new drug HS-10587 tablets have obtained the drug clinical trial approval notification issued by the China National Medical Products Administration. It is intended to conduct clinical trials for late-stage solid tumors with MTAP deficiency.
4 m ago
Hansen Pharmaceuticals announced that the Group's independently developed new drug HS-20152 injection has obtained the drug clinical trial approval notification issued by the China National Medical Products Administration, and intends to conduct clinical trials for paroxysmal nocturnal hemoglobinuria.
See all latest